1. Home
  2. PETS vs HOOK Comparison

PETS vs HOOK Comparison

Compare PETS & HOOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PETS
  • HOOK
  • Stock Information
  • Founded
  • PETS 1996
  • HOOK 2011
  • Country
  • PETS United States
  • HOOK United States
  • Employees
  • PETS N/A
  • HOOK 124
  • Industry
  • PETS Retail-Drug Stores and Proprietary Stores
  • HOOK Biotechnology: Pharmaceutical Preparations
  • Sector
  • PETS Consumer Staples
  • HOOK Health Care
  • Exchange
  • PETS Nasdaq
  • HOOK Nasdaq
  • Market Cap
  • PETS 87.1M
  • HOOK 61.8M
  • IPO Year
  • PETS N/A
  • HOOK 2019
  • Fundamental
  • Price
  • PETS $3.86
  • HOOK $6.19
  • Analyst Decision
  • PETS Buy
  • HOOK Strong Buy
  • Analyst Count
  • PETS 2
  • HOOK 3
  • Target Price
  • PETS $5.25
  • HOOK $50.00
  • AVG Volume (30 Days)
  • PETS 484.6K
  • HOOK 56.2K
  • Earning Date
  • PETS 08-06-2024
  • HOOK 08-08-2024
  • Dividend Yield
  • PETS 7.79%
  • HOOK N/A
  • EPS Growth
  • PETS N/A
  • HOOK N/A
  • EPS
  • PETS N/A
  • HOOK N/A
  • Revenue
  • PETS $281,064,000.00
  • HOOK $53,552,000.00
  • Revenue This Year
  • PETS $2.07
  • HOOK $172.70
  • Revenue Next Year
  • PETS $4.31
  • HOOK N/A
  • P/E Ratio
  • PETS N/A
  • HOOK N/A
  • Revenue Growth
  • PETS 9.54
  • HOOK 235.12
  • 52 Week Low
  • PETS $3.63
  • HOOK $4.10
  • 52 Week High
  • PETS $15.08
  • HOOK $11.30
  • Technical
  • Relative Strength Index (RSI)
  • PETS 47.70
  • HOOK 46.51
  • Support Level
  • PETS $3.77
  • HOOK $6.01
  • Resistance Level
  • PETS $3.94
  • HOOK $6.68
  • Average True Range (ATR)
  • PETS 0.16
  • HOOK 0.50
  • MACD
  • PETS 0.01
  • HOOK 0.12
  • Stochastic Oscillator
  • PETS 58.00
  • HOOK 73.10

About PETS PetMed Express Inc.

PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies primarily to retail consumers.

About HOOK HOOKIPA Pharma Inc.

HOOKIPA Pharma Inc is a clinical stage biopharmaceutical company developing a class of immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform that is designed to reprogram the body's immune system. It uses off-the-shelf technologies, VaxWave and TheraT, to elicit directly within patients a response of antigen-specific killer T cells and antibodies.

Share on Social Networks: